Project Grant HT94252411032
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Awardee
Metis Foundation (CYYCLBFLP125)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78216, USA
Similar Awards
The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
The federal Project Grant award of $1,034,071 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the Metis Foundation on "PROSTATE-SPECIFIC ANTIANDROGEN THERAPY FOR LOCALIZED PROSTATE CANCER." The research aims to develop innovative prostate cancer therapies, building upon Metis Foundation's expertise in conducting medical research, education, and project management support for the military health...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
The Cooperative Agreement award of $1,987,608.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Metis Foundation in improving severe burn resuscitation outcomes through the use of icatibant, an FDA-approved bradykinin B2 receptor antagonist. This 2-year project, running from September 2023 to September 2025, aims to develop innovative medical technologies and conduct research to transform care for military service members...
The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...